KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Non-Current Liabilities (2016 - 2025)

AbbVie (ABBV) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $105.3 billion as the latest value for Q2 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 7.58% to $105.3 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $105.3 billion, a 7.58% decrease, with the full-year FY2024 number at $101.7 billion, down 2.6% from a year prior.
  • Total Non-Current Liabilities was $105.3 billion for Q2 2025 at AbbVie, up from $103.5 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $124.2 billion in Q1 2021 to a low of $101.7 billion in Q4 2024.
  • A 5-year average of $111.1 billion and a median of $111.9 billion in 2022 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: soared 36.15% in 2021, then decreased 14.22% in 2025.
  • AbbVie's Total Non-Current Liabilities stood at $116.2 billion in 2021, then fell by 9.53% to $105.1 billion in 2022, then decreased by 0.68% to $104.4 billion in 2023, then decreased by 2.6% to $101.7 billion in 2024, then grew by 3.56% to $105.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Total Non-Current Liabilities are $105.3 billion (Q2 2025), $103.5 billion (Q1 2025), and $101.7 billion (Q4 2024).